Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.14% | 10.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.14% | 10.96% | |||
| Cost of Revenue | 20.63% | -10.05% | |||
| Gross Profit | -21.13% | 22.49% | |||
| SG&A Expenses | 57.51% | 3.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 53.20% | 2.11% | |||
| Operating Income | -95.53% | 3.19% | |||
| Income Before Tax | -508.45% | 11.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -508.45% | 11.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -508.45% | 11.43% | |||
| EBIT | -95.53% | 3.19% | |||
| EBITDA | -96.44% | 3.23% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -0.77% | 1.04% | |||
| Average Diluted Shares Outstanding | -0.77% | 1.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||